Przejdź do
Zaloguj się, aby wyświetlić ceny organizacyjne i kontraktowe.
Wybierz wielkość
Zmień widok
| Rozmiar/SKU | Dostępność | Cena netto |
|---|
Informacje o tej pozycji
Form:
solution
Storage temp.:
−20°C
Informacje o cenach i dostępności nie są obecnie dostępne.
Pomoc techniczna
Potrzebujesz pomocy? Nasz zespół doświadczonych naukowców chętnie Ci pomoże.
Pozwól nam pomócform
solution
packaging
vial of 25 μmol
manufacturer/tradename
Roche 10436492001
storage temp.
−20°C
General description
Cytidine triphosphate (CTP), along with adenosine triphosphate (ATP), )Guanosine-5′-triphosphate (GTP , uridine triphosphate (UTP), and potentially modified UTP, is part of the ribonucleotide mix required for synthesizing messenger RNA (mRNA) during transcription. This process occurs in the presence of RNA polymerase, which catalyzes the formation of RNA from the DNA template using these ribonucleotides.
Application
Guanosine-5′-triphosphate (GTP), cytidine triphosphate (CTP), adenosine triphosphate (ATP), and uridine triphosphate (UTP) are essential nucleotides involved in RNA synthesis. A significant application for these nucleotides is in vitro transcription (IVT) of mRNA, which is widely used in research and experimental studies.IVT kits incorporate these nucleotides to synthesize mRNA from DNA templates, enabling the production of RNA for various applications, including gene expression analysis and functional studies. However, off-the-shelf kits can restrict researchers′ ability to optimize the concentrations and ratios of these nucleotides according to the specific characteristics of different mRNA molecules, such as their composition and length. This limitation can impact the efficiency and quality of the synthesized mRNA. As a result, there is a growing interest in developing customizable approaches that allow for greater flexibility in reagent optimization, enhancing the performance of IVT reactions to better suit specific experimental requirements.
Features and Benefits
Scalable mRNA Synthesis: Designed for scalable mRNA production, suitable for both small-scale laboratory research and large-scale applications in biotechnology and pharmaceuticals.
Ta strona może zawierać tekst przetłumaczony maszynowo.
1 of 1
Ta pozycja | |||
|---|---|---|---|
| description vial of 25 μmol, (Animal Origin Free, Antibiotic Free Production, Extended Impurity tested) | description vial of 25 μmol, (Animal Origin Free, Antibiotic Free Production, Extended Impurity tested) | description vial of 25 μmol, (Animal Origin Free, Antibiotic Free Production, Extended Impurity tested) | description =98%, solution, 100 mM, suitable for DNA sequencing, suitable for DNA amplification |
| manufacturer/tradename Roche 10436492001 | manufacturer/tradename Roche 10436468001 | manufacturer/tradename Roche 10436034001 | manufacturer/tradename Roche |
| form solution | form solution | form solution | form solution |
| storage temp. −20°C | storage temp. −20°C | storage temp. −20°C | storage temp. −20°C |
| packaging vial of 25 μmol | packaging vial of 25 μmol | packaging vial of 25 μmol | packaging pkg of 250 μL (25 μmol) |
Wybierz jedną z najnowszych wersji:
Masz już ten produkt?
Dokumenty związane z niedawno zakupionymi produktami zostały zamieszczone w Bibliotece dokumentów.



